Beacon Capital Management, LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 84 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Beacon Capital Management, LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,550
-5.6%
5,0000.0%0.00%
-33.3%
Q4 2022$8,000
-11.1%
5,0000.0%0.00%0.0%
Q3 2022$9,0005,0000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders